Most people had not heard of Ivermectin until the fall of 2021, however, as you will read, it has been around for a very long time. Many patients chose to utilize this treatment option for Covid due to its anti-viral benefits and many providers are prescribing it for Long Covid in a widely prescribed treatment protocol. Lately we have been getting many questions at the pharmacy about the utilization of Ivermectin for cancer due to two recently published studies on this topic. Today we will look at those studies and the basis behind its potential benefit for cancer treatment.
Ivermectin is a drug that has been widely used for decades to treat parasitic infections in humans and animals.
Originally developed to fight diseases like river blindness and scabies, ivermectin has recently gained attention for its potential role in cancer treatment. This interest is based on research, including the studies "Antitumor Effects of Ivermectin at Clinically Feasible Concentrations Support Its Clinical Development as a Repositioned Cancer Drug" and "Targeting the Mitochondrial-Stem Cell Connection in Cancer Treatment: A Hybrid Orthomolecular Protocol." These studies suggest that ivermectin could be repurposed as a cancer drug due to its unique properties.
Ivermectin is an anti-parasitic medication discovered in the 1970s. It works by paralyzing and killing parasites, making it an effective treatment for infections caused by worms and certain skin conditions. It has been considered safe when used properly and has even been listed as an essential medicine by the World Health Organization (WHO).
Recent studies have shown that ivermectin may have antitumor effects, meaning it can help stop the growth of cancer cells. The 2020 study "Antitumor Effects of Ivermectin at Clinically Feasible Concentrations Support Its Clinical Development as a Repositioned Cancer Drug" explains how ivermectin can target cancer cells in several ways:
Disrupting Cell Division:
Cancer cells grow uncontrollably because they divide rapidly. Ivermectin interferes with the proteins that help cells divide, which slows down or stops the growth of tumors.
Inducing Apoptosis: Apoptosis is a process where damaged or unneeded cells "self-destruct." Many cancer cells avoid this process, which helps them survive longer than normal cells. Ivermectin can trigger apoptosis in cancer cells, leading to their death.
Inhibiting Cancer Stem Cells: Cancer stem cells are a small group of cells within tumors that can start new growth and cause cancer to spread. Ivermectin has shown promise in targeting these stem cells, reducing the chances of cancer returning after treatment.
Blocking Energy Production:
Cancer cells need a lot of energy to grow and spread. Ivermectin can interfere with the mitochondria, the "powerhouses" of cells, reducing the energy supply that cancer cells need to survive.
The second study from 2024, "Targeting the Mitochondrial-Stem Cell Connection in Cancer Treatment: A Hybrid Orthomolecular Protocol,"
focuses on how cancer stem cells rely heavily on mitochondria for energy. Mitochondria are tiny structures inside cells that produce energy from nutrients. In cancer stem cells, these mitochondria are often more active than in normal cells.
Ivermectin disrupts this mitochondrial function, making it harder for cancer stem cells to survive. This is important because cancer stem cells are usually resistant to traditional treatments like chemotherapy and radiation. By targeting the mitochondria, ivermectin can weaken these cells, making them more vulnerable to other cancer therapies.
One of the exciting possibilities discussed in these studies is combining ivermectin with other cancer treatments. This approach is known as a "hybrid orthomolecular protocol."
It involves using natural substances and drugs together to improve treatment outcomes.
Ivermectin, when used alongside chemotherapy, radiation, or other drugs, may enhance their effectiveness.
This is because it weakens cancer cells, making them more sensitive to traditional treatments. Additionally, by targeting cancer stem cells, ivermectin could help prevent cancer from coming back after initial treatment.
While these studies show promising results, it is important to remember that most of the research has been done in laboratory settings or on animals. Clinical trials in humans are necessary to confirm the safety and effectiveness of ivermectin as a cancer treatment.
The dosing of Ivermectin is often based on an individual’s weight
and therefore having a healthcare provider involved in this process is highly recommended. Ivermectin is generally safe when used correctly for parasitic infections, but high doses or improper use can cause side effects. These can include dizziness, nausea, skin rashes, and, in rare cases, more serious problems like seizures. Therefore, it should never be used for cancer treatment without the supervision of a qualified healthcare professional.
The potential for ivermectin as a cancer drug is an exciting area of research. Its ability to target cancer cells, disrupt energy production, and enhance the effects of other treatments makes it a promising candidate for future cancer therapies. However, more studies and clinical trials are needed to fully understand how it works and to ensure it is safe and effective for cancer patients.
While ivermectin was originally designed to treat parasitic infections, new research suggests it could play a role in cancer treatment. By targeting the unique characteristics of cancer cells and stem cells, ivermectin might help improve outcomes for patients in the future. As with any potential new treatment, it is essential to rely on scientific evidence and consult healthcare professionals before considering its use.
If you would like more information about Ivermectin, please call the pharmacy @ 701-483-4858 or stop in to schedule a consultation. Please visit my website at
www.irsfeldpharmacy.com
to find this and other archived articles in the blog section.
Until next time, be vigilant about your health!!!
Share On: